Macular Edema Secondary To Retinal Vein Occlusion clinical trials

Explore recruiting macular edema secondary to retinal vein occlusion clinical trials.

Also recruiting in Europe

Macular Edema Secondary To Retinal Vein Occlusion trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(22153) Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion

France, Slovakia, Portugal, Lithuania, Hungary, Spain +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Macular Edema Secondary To Retinal Vein Occlusion trials by city

Macular Edema Secondary To Retinal Vein Occlusion in Toronto Macular Edema Secondary To Retinal Vein Occlusion in Vancouver Macular Edema Secondary To Retinal Vein Occlusion in Montreal Macular Edema Secondary To Retinal Vein Occlusion in Calgary Macular Edema Secondary To Retinal Vein Occlusion in Edmonton Macular Edema Secondary To Retinal Vein Occlusion in Ottawa Macular Edema Secondary To Retinal Vein Occlusion in Winnipeg Macular Edema Secondary To Retinal Vein Occlusion in Quebec City Macular Edema Secondary To Retinal Vein Occlusion in Hamilton Macular Edema Secondary To Retinal Vein Occlusion in Kitchener Macular Edema Secondary To Retinal Vein Occlusion in London Macular Edema Secondary To Retinal Vein Occlusion in Halifax Macular Edema Secondary To Retinal Vein Occlusion in New York Macular Edema Secondary To Retinal Vein Occlusion in Los Angeles Macular Edema Secondary To Retinal Vein Occlusion in Chicago Macular Edema Secondary To Retinal Vein Occlusion in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease